Here's the live share price of Alkem Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Alkem Laboratories has gained 14.17% CAGR. Over the past year, the corresponding return has been -9.45%.
Alkem Laboratories’s current P/E of 29.09x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
Ajanta Pharma | -1.07 | -5.76 | 0.27 | -2.77 | -20.40 | 26.20 | 19.22 |
Over the last one year, Alkem Laboratories has declined 9.45% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, Alkem Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Day | SMA | EMA |
---|---|---|
5 | 5,465.29 | 5,464.8 |
10 | 5,393.91 | 5,427.55 |
20 | 5,376.95 | 5,364.96 |
50 | 5,147.78 | 5,223.88 |
100 | 5,076.64 | 5,140.32 |
200 | 5,084.43 | 5,132.19 |
In the latest quarter, Alkem Laboratories saw a drop in promoter holding to 53.04%, while DII stake increased to 21.80%, FII holding fell to 9.11%, and public shareholding unchanged at 16.05% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
ICICI Prudential Multi Asset Fund | 14,99,220 | 1.23 | 795.11 |
SBI Large & Midcap Fund | 14,76,712 | 2.36 | 783.17 |
ICICI Prudential Large & Mid Cap Fund | 13,59,803 | 3.04 | 721.17 |
Nippon India Growth Fund | 11,63,397 | 1.61 | 617.01 |
SBI Contra Fund | 10,04,007 | 1.14 | 532.48 |
DSP Mid Cap Fund | 7,48,010 | 2.08 | 396.71 |
SBI Magnum Midcap Fund | 6,85,892 | 1.65 | 363.76 |
ICICI Prudential ELSS Tax Saver Fund | 5,86,038 | 2.17 | 310.81 |
ICICI Prudential India Opportunities Fund | 5,71,629 | 1.01 | 303.16 |
ICICI Prudential Equity & Debt Fund | 5,10,936 | 0.6 | 270.97 |
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Sep 18, 2025, 6:09 AM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Sep 17, 2025, 9:19 PM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Sep 17, 2025, 12:29 AM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Sep 09, 2025, 5:58 AM IST | Alkem Laboratories - Announcement Under Reg 30 (LODR)- Cancellation Of Analyst / Institutional Investor Meeting Scheduled On |
Sep 08, 2025, 5:59 AM IST | Alkem Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 8813.44 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Alkem Laboratories is ₹5,558.20 as on Sep 19, 2025.
The Alkem Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Alkem Laboratories is ₹66,456.62 Cr as on Sep 19, 2025.
Today’s highest and lowest price of Alkem Laboratories are ₹5,571.50 and ₹5,494.05.
The 52-week high/low is the highest and lowest price at which Alkem Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Alkem Laboratories is ₹6,369.00 and 52-week low of Alkem Laboratories is ₹4,498.90 as on Sep 19, 2025.
The Alkem Laboratories has shown returns of 1.45% over the past day, 3.13% for the past month, 16.34% over 3 months, -9.45% over 1 year, 19.64% across 3 years, and 14.17% over 5 years.
P/E ratio of and PB ratio of Alkem Laboratories are 29.09 and 5.78 on Sep 19, 2025. While the company gives a dividend yield of 0.81 per annum.